Zelis Owners in Talks to Sell Stake at $17 Billion Value.

PARTHENON (Athens, Greece) ; J.P. Morgan Chase & Co. ; BAIN Capital LLC

Bain Capital and Parthenon Capital are reportedly in discussions to sell a minority stake in Zelis, a health-care technology company, at a valuation of around $17 billion. The private equity firms are considering selling a 20% to 25% stake in Zelis and have received preliminary interest from health-insurers, a payments company, buyout firms, and sovereign wealth funds. Bain and Parthenon are being advised by Goldman Sachs and JPMorgan, and they are leaning towards a stake sale to continue benefiting from Zelis' growth. Zelis operates a platform that digitizes payments in the health-care industry, working with health payers to manage claims and save money. [Extracted from the article]

Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)